Todd Hannigan Acquires 225,000 Shares of IperionX (NASDAQ:IPX) Stock

IperionX Limited Sponsored ADR (NASDAQ:IPXGet Free Report) Chairman Todd Hannigan bought 225,000 shares of the business’s stock in a transaction on Friday, July 10th. The shares were acquired at an average price of $3.58 per share, for a total transaction of $805,500.00. Following the completion of the transaction, the chairman owned 26,333,334 shares in the company, valued at approximately $94,273,335.72. This trade represents a 0.86% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Todd Hannigan also recently made the following trade(s):

  • On Monday, July 13th, Todd Hannigan bought 300,000 shares of IperionX stock. The stock was acquired at an average cost of $3.59 per share, for a total transaction of $1,077,000.00.
  • On Tuesday, April 28th, Todd Hannigan purchased 220,000 shares of IperionX stock. The shares were acquired at an average price of $4.48 per share, with a total value of $985,600.00.
  • On Wednesday, April 29th, Todd Hannigan purchased 260,000 shares of IperionX stock. The shares were acquired at an average price of $4.20 per share, with a total value of $1,092,000.00.

IperionX Stock Up 3.3%

IPX opened at $25.49 on Wednesday. The firm has a 50 day simple moving average of $33.94 and a 200 day simple moving average of $37.34. IperionX Limited Sponsored ADR has a fifty-two week low of $21.66 and a fifty-two week high of $61.45. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00.

More IperionX News

Here are the key news stories impacting IperionX this week:

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. GAMMA Investing LLC increased its stake in IperionX by 40.3% in the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock valued at $50,000 after purchasing an additional 483 shares in the last quarter. JPMorgan Chase & Co. bought a new position in shares of IperionX during the second quarter worth $66,000. State of Tennessee Department of Treasury bought a new position in shares of IperionX during the fourth quarter worth $119,000. DV Equities LLC acquired a new position in shares of IperionX in the 4th quarter valued at $178,000. Finally, Man Group plc acquired a new position in shares of IperionX in the 4th quarter valued at $257,000. Institutional investors and hedge funds own 2.76% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on IPX. BTIG Research upped their target price on shares of IperionX from $40.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, June 5th. Alliance Global Partners reaffirmed a “buy” rating on shares of IperionX in a research note on Tuesday, April 28th. Weiss Ratings reiterated a “sell (e+)” rating on shares of IperionX in a report on Tuesday, April 21st. Finally, Roth Capital reiterated a “buy” rating on shares of IperionX in a report on Monday, June 8th. Five research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $60.33.

Get Our Latest Research Report on IperionX

About IperionX

(Get Free Report)

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high?purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.

Recommended Stories

Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.